Concepedia

Miriam Krischke

MK

Statistics

Publications

9

Citations

312

H-Index

9

Active since

2003

Affiliations

University of Münster(Current)

University Hospital Münster

Newcastle University

The University of Sydney

Mario Negri Institute for Pharmacological Research

Miriam Krischke is an author at University of Münster specializing in pharmacology, pharmacokinetics of anticancer agents, and pharmacy.

ORCID

Publications per year

2003–2020

9

Publications

9

Tyrosine phosphatase inhibition induces loss of blood–brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways

Christina Lohmann, Miriam Krischke, Joachim Wegener et al. · Brain Research · 2003 · 96 citations

, , +16

Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years

Nina E. Kontny, Gudrun Würthwein, Joachim Boos et al. · Cancer Chemotherapy and Pharmacology · 2013 · 48 citations · Full text

, , +14

Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a “European Pediatric Oncology Off-patents Medicines Consortium” trial

Miriam Krischke, Georg Hempel, Swantje Völler et al. · Cancer Chemotherapy and Pharmacology · 2016 · 36 citations · Full text

, , +17

Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer

Swantje Völler, Joachim Boos, Miriam Krischke et al. · Clinical Pharmacokinetics · 2015 · 34 citations

, , +12

<i>Dictyostelium</i>Dock180-related RacGEFs Regulate the Actin Cytoskeleton during Cell Motility

Alessia Para, Miriam Krischke, Sylvain Merlot et al. · Molecular Biology of the Cell · 2008 · 28 citations · Full text

, , +17

1–5 of 9